Please assess the completion status of the following clinical trial:

Trial Title: Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients of American Society of Anesthesiologist(ASA) physical status 1 \& 2 requiring general anesthesia with endotracheal intubation.~* Duration of surgery more than 90 min~Exclusion Criteria:~* Those with preexisting hoarseness or sorethroat~* Smoker~* Vocal performer by occupation~* Recent or recurrent respiratory tract infection~* Risk factors for postoperative aspiration~* Obesity~* Pregnancy~* Receiving analgesics, corticosteroids and calcium channel blockers~* Contraindication to corticosteroid medications~* Anticipated difficult intubation~* Mallampati grade \> 2~* Difficult mask ventilation requiring oral or nasal airway~* Cormack and Lehman grade III and IV on laryngoscopy~* More than one intubation attempt~* Those requiring orogastric or nasogastric tubes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Group LD: Lidocaine and Dexamethasone (Type: EXPERIMENTAL): lidocaine 1.5 mg/kg and dexamethasone (dexona) 8 mg iv prior to induction of anesthesia
- Group L: Lidocaine (Type: ACTIVE_COMPARATOR): Group L: lidocaine 1.5 mg/kg iv prior to induction of anesthesia
- D: Dexamethasone (Type: ACTIVE_COMPARATOR): Dexamethasone 8 mg iv prior to induction of anesthesia
- N: normal saline (Type: PLACEBO_COMPARATOR): N: normal saline (placebo): 2 ml

Based on this trial design, predict the completion outcome and termination type (if applicable).